Publication Scheme

Introduction

This Guide to Information sets out the information that Evernu Ltd routinely makes available to the public. It is adopted in accordance with the principles of the ICO Model Publication Scheme and reflects Evernu Ltd’s commitment to openness and transparency in the delivery of regulated telehealth services.

Evernu Ltd is a private independent healthcare provider registered with the Regulation and Quality Improvement Authority (RQIA), Northern Ireland. While the Freedom of Information Act 2000 applies directly to public authorities, Evernu Ltd voluntarily adopts this publication scheme as a condition of RQIA registration and as a demonstration of good governance.

All information listed below is available free of charge unless otherwise stated. Where information is not available online, requests may be submitted to help@evernu.co.uk.

Class 1 – Who We Are and What We Do

Organisational information, structure, locations, and contacts.

• Legal Name: Evernu Ltd
• Company Registration: Company No. NI729459 (registered in Northern Ireland)
• Regulatory Status: Regulated by the Regulation and Quality Improvement Authority (RQIA) as an independent telehealth provider. RQIA registration number to be inserted upon confirmation.
• ICO Registration: Registered with the Information Commissioner’s Office (ICO) in accordance with UK GDPR. ICO registration reference: ZC081786.
• Registered Manager: Dr Michael Gough – Medical Director and Registered Manager
• Business Model: Telehealth services delivered remotely (online consultations). No physical patient-facing premises.
• General Enquiries & FOI Contact:help@evernu.co.uk
• Website:evernu.co.uk

Class 2 – What We Spend and How We Spend It

Financial information relating to the organisation’s expenditure and income.

• Annual Accounts: Evernu Ltd is a private limited company. Statutory accounts are filed annually with Companies House and are publicly accessible via Companies House (Company No. NI729459).
• Funding Sources: Evernu Ltd does not receive public funding. Revenue is generated entirely from private patient fees.
• Fee Schedule: Up-to-date fees for all clinical services are published at evernu.co.uk/fee-schedule. There are no hidden charges. Delivery costs are included in all published prices.
• Public Contracts: Evernu Ltd does not hold or administer public contracts.

Class 3 – What Our Priorities Are and How We Are Doing

Information about our strategy, performance, and quality of services.

• Strategic Aim: Evernu Ltd is committed to delivering safe, effective, and accessible telehealth services in the areas of Testosterone Replacement Therapy (TRT) and medically supervised weight management (GLP-1 treatments). Our clinical governance framework ensures continuous quality improvement.
• Inspection Reports: RQIA inspection reports, once issued, will be made publicly available on the RQIA website (rqia.org.uk) and linked from evernu.co.uk.
• Quality & Outcomes: Patient satisfaction and outcomes are monitored through structured follow-up processes under the oversight of our Medical Director.
• Significant Incidents: Significant incidents are managed in accordance with our Clinical Governance Policy and reported to RQIA where required under the Independent Health Care Regulations (Northern Ireland) 2005.

Class 4 – How We Make Decisions

Information about our decision-making processes and governance.

• Clinical Decision-Making: Clinical decisions are made by our registered clinicians under the oversight of Dr Michael Gough (Medical Director). All prescribing follows evidence-based clinical protocols.
• Governance Structure: Commercial and operational decisions are made by the board of directors of Evernu Ltd. Board members include the Medical Director and business directors.
• Complaints & Learning: Evernu Ltd operates a formal complaints process. Outcomes of complaints are reviewed at board level and used to drive service improvement. See evernu.co.uk/make-a-complaint.
• Regulatory Compliance in Decision-Making: Patient treatment decisions are made in accordance with GMC guidance, NICE clinical pathways, and applicable MHRA regulations.

Class 5 – Our Policies and Procedures

Current written policies and protocols governing service delivery and legal obligations.

• Privacy Notice & Data Protection Policy: Available at evernu.co.uk/privacy-notice. Covers UK GDPR compliance, data retention, patient confidentiality, and rights of data subjects.
• Complaints Policy: Available at evernu.co.uk/make-a-complaint. Sets out how patients can raise concerns and how Evernu Ltd will respond.
• Clinical Governance Policy: Evernu Ltd operates a clinical governance framework covering patient safety, prescribing protocols, adverse event reporting, and staff competency.
• Safeguarding Policy: Evernu Ltd maintains a safeguarding policy in line with applicable Northern Ireland legislation and RQIA guidance.
• Equality & Diversity: Policies covering equality, diversity and inclusion in service delivery and employment.
• Other Policies: Available upon request to help@evernu.co.uk.

Class 6 – Lists and Registers

Key registers and lists maintained by Evernu Ltd.

• RQIA Register of Providers: Evernu Ltd is listed on the RQIA public register of independent healthcare providers (rqia.org.uk).
• ICO Data Protection Register: Evernu Ltd is registered with the Information Commissioner’s Office under UK GDPR (reference ZC081786, Tier 1). ICO registration details are publicly verifiable on the ICO register at ico.org.uk.
• Companies House Register: Evernu Ltd is registered with Companies House, Northern Ireland. Company No. NI729459.
• Clinician Registration: Dr Michael Gough is registered with the General Medical Council (GMC). GMC registration details are publicly verifiable at gmc-uk.org.

Class 7 – Services We Offer

Information about the clinical services and patient pathways available through Evernu Ltd.

• Testosterone Replacement Therapy (TRT): Online consultations, clinical assessment, prescribing and ongoing management of testosterone deficiency.
• Weight Management (GLP-1 Treatments): Medically supervised weight loss using GLP-1 receptor agonists (including Mounjaro and Wegovy), with clinical assessment, prescribing, and ongoing monitoring.
• Diagnostic Blood Testing (Phlebotomy): Blood testing associated with TRT clinical assessment and ongoing monitoring.
• Service Delivery Model: All clinical services are delivered via secure online consultation. Prescriptions are fulfilled through registered UK pharmacies.
• Fees: Up-to-date pricing for all services is available at evernu.co.uk/fee-schedule.
• Eligibility: All services are available to adults aged 18 and over. Services are not available to individuals under 18.

How to Access This Information

All information listed in this guide is available free of charge online via the links provided. For individuals who are unable to access information online, printed copies of any disclosure can be requested by emailing help@evernu.co.uk.

If you wish to request information not listed in this guide, please contact us at help@evernu.co.uk. We will respond within 20 working days.